Your browser doesn't support javascript.
loading
Low-dose candesartan prevents schizophrenia-like behavioral alterations in a neurodevelopmental two-hit model of schizophrenia.
Vasconcelos, Germana Silva; Dos Santos Júnior, Manuel Alves; Monte, Aline Santos; da Silva, Francisco Eliclécio Rodrigues; Lima, Camila Nayane de Carvalho; Moreira Lima Neto, Abelardo Barbosa; Medeiros, Ingridy da Silva; Teixeira, Antonio Lucio; de Lucena, David Freitas; Vasconcelos, Silvânia Maria Mendes; Macedo, Danielle S.
Afiliação
  • Vasconcelos GS; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Dos Santos Júnior MA; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Monte AS; University of International Integration of Afro-Brazilian Lusophony (Unilab-CE), Brazil.
  • da Silva FER; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Lima CNC; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Moreira Lima Neto AB; Christus University Center (Unichristus-CE), Fortaleza, CE, Brazil.
  • Medeiros IDS; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Teixeira AL; Institute of Education and Research, Santa Casa BH, Belo Horizonte, Brazil; Neuropsychiatry Program, Department of Psychiatry and Behavioral Sciences, UTHealth Houston, United States of America.
  • de Lucena DF; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Vasconcelos SMM; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil.
  • Macedo DS; Drug Research and Development Center, Department of Physiology and Pharmacology, Faculty of Medicine, Federal University of Ceara, Fortaleza, CE, Brazil; National Institute for Translational Medicine (INCT-TM, CNPq), Ribeirão Preto, SP, Brazil. Electronic address: danielle.macedo@ufc.br.
Prog Neuropsychopharmacol Biol Psychiatry ; 111: 110348, 2021 12 20.
Article em En | MEDLINE | ID: mdl-33984421
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Tetrazóis / Benzimidazóis / Compostos de Bifenilo / Fármacos Neuroprotetores / Receptor Tipo 1 de Angiotensina / Bloqueadores do Receptor Tipo 1 de Angiotensina II Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esquizofrenia / Tetrazóis / Benzimidazóis / Compostos de Bifenilo / Fármacos Neuroprotetores / Receptor Tipo 1 de Angiotensina / Bloqueadores do Receptor Tipo 1 de Angiotensina II Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: En Revista: Prog Neuropsychopharmacol Biol Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Brasil País de publicação: Reino Unido